The results indicated that PFS and OS were slightly longer in the luminal groups than in the HER2‐positive and TN groups, suggesting that the variation in the survival time for each BC subtype followed a similar trend to lymphocyte distribution. The gene discussed is ERBB2; the disease is breast cancer.